Researchers look to the emerging phenomenon of "crowdfunding" to pay for their work
The Scientist
Most Recent
The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.
Proposals from researchers receiving more than $1 million a year in NIH funding will be carefully picked over to avoid overlap with ongoing research.
The rise in the amount of federal money requested through research grants is due to a rise in the overall number of applicants.
The United Kingdom's Wellcome Trust announces that it will begin sanctioning researchers who do not submit manuscripts to the public UK PubMed Central database.
The Senate approves an increase of about 0.3 percent for the 2013 NIH budget, but the Department of Energy doesn’t fare as well.
A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.
Plant research remains grossly underfunded, despite the demand for increased crop production to support a growing population.
A petition asking for online, readable publication of all government-funded research is making its way to the White House.
The University of Michigan is funding exploratory ideas that cross disciplinary boundaries with $20,000 a pop.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
